Matches in SemOpenAlex for { <https://semopenalex.org/work/W2122520003> ?p ?o ?g. }
- W2122520003 endingPage "329" @default.
- W2122520003 startingPage "323" @default.
- W2122520003 abstract "Nonsteroidal antiinflammatory drugs have become increasingly popular as part of multimodal analgesic regimens for pain management in the ambulatory setting. We designed this randomized, double-blind, placebo-controlled study to evaluate the effect of postoperative administration of either a nonselective nonsteroidal antiinflammatory drug (ibuprofen) or the cyclooxygenase-2 selective inhibitor (celecoxib when administered as part of a multimodal analgesic regimen) on the severity of pain, the need for rescue analgesics, and clinically relevant patient outcomes after ambulatory surgery. The primary end point was the time to resumption of normal activities of daily living.One hundred eighty patients undergoing outpatient surgery were randomly assigned to 1 of 3 treatment groups: group 1 (control) received either 2 placebo capsules (matching celecoxib) or 1 placebo tablet (matching ibuprofen) in the recovery room and 1 placebo tablet at bedtime on the day of surgery, followed by 1 placebo capsule or tablet 3 times a day for 3 days after discharge; group 2 (celecoxib) received celecoxib 400 mg (2 capsules) orally in the recovery room and 1 placebo capsule and tablet at bedtime on the day of surgery, followed by celecoxib 200 mg (1 capsule) twice a day + placebo capsule every day at bedtime for 3 days after surgery; or group 3 (ibuprofen) received ibuprofen 400 mg (1 tablet) orally in the recovery room and 400 mg orally at bedtime on the day of surgery, followed by 400 mg orally 3 times a day for 3 days after surgery. Recovery times, postoperative pain scores, and the need for rescue analgesics were recorded before discharge. Follow-up evaluations were performed at 24 hours, 48 hours, 72 hours, 7 days, and 30 days after surgery to assess postdischarge pain, analgesic requirements, resumption of normal activities, opioid-related side effects, as well as quality of recovery and patient satisfaction with their postoperative pain management using a 5-point verbal rating scale.The 3 groups did not differ with respect to their demographic characteristics. Compared with the placebo treatment, both celecoxib and ibuprofen significantly decreased the need for rescue analgesic medication after discharge (P < 0.05). The effect sizes (celecoxib and ibuprofen versus control group) were 0.73 to 1 and 0.3 to 0.8, respectively. Quality of recovery scores and patient satisfaction with their postoperative pain management were also improved in the celecoxib and ibuprofen groups compared with the control group (P < 0.05, effect size [vs control group] = 0.67). The incidence of postoperative constipation was significantly higher in the control group (28%) compared with the celecoxib (5%) and ibuprofen (7%) groups, respectively (P < 0.05). Both active treatments were well tolerated in the postdischarge period. However, the time to resumption of normal activities of daily living was similar among the 3 groups.Both ibuprofen (1200 mg/d) and celecoxib (400 mg/d) significantly decreased the need for rescue analgesic medication in the early postdischarge period, leading to an improvement in the quality of recovery and patient satisfaction with their pain management after outpatient surgery." @default.
- W2122520003 created "2016-06-24" @default.
- W2122520003 creator A5005595554 @default.
- W2122520003 creator A5006663041 @default.
- W2122520003 creator A5027565228 @default.
- W2122520003 creator A5034429046 @default.
- W2122520003 creator A5051774923 @default.
- W2122520003 creator A5052437588 @default.
- W2122520003 creator A5058897716 @default.
- W2122520003 creator A5070015565 @default.
- W2122520003 creator A5072213670 @default.
- W2122520003 creator A5073265415 @default.
- W2122520003 creator A5081758472 @default.
- W2122520003 creator A5083303292 @default.
- W2122520003 creator A5091887287 @default.
- W2122520003 date "2011-02-01" @default.
- W2122520003 modified "2023-10-16" @default.
- W2122520003 title "The Effects of Oral Ibuprofen and Celecoxib in Preventing Pain, Improving Recovery Outcomes and Patient Satisfaction After Ambulatory Surgery" @default.
- W2122520003 cites W192234595 @default.
- W2122520003 cites W1985793204 @default.
- W2122520003 cites W1986214392 @default.
- W2122520003 cites W1996353828 @default.
- W2122520003 cites W1998167638 @default.
- W2122520003 cites W2010616681 @default.
- W2122520003 cites W2021313793 @default.
- W2122520003 cites W2024576769 @default.
- W2122520003 cites W2032779979 @default.
- W2122520003 cites W2033175053 @default.
- W2122520003 cites W2048761708 @default.
- W2122520003 cites W2049048114 @default.
- W2122520003 cites W2061634909 @default.
- W2122520003 cites W2070466005 @default.
- W2122520003 cites W2071969157 @default.
- W2122520003 cites W2077340116 @default.
- W2122520003 cites W2078586295 @default.
- W2122520003 cites W2086593341 @default.
- W2122520003 cites W2091384798 @default.
- W2122520003 cites W2113763449 @default.
- W2122520003 cites W2115712316 @default.
- W2122520003 cites W2130141996 @default.
- W2122520003 cites W2133347503 @default.
- W2122520003 cites W2133403261 @default.
- W2122520003 cites W2139776244 @default.
- W2122520003 cites W2149303604 @default.
- W2122520003 cites W2153567324 @default.
- W2122520003 cites W2154493320 @default.
- W2122520003 cites W2165499321 @default.
- W2122520003 cites W2214895385 @default.
- W2122520003 cites W2320845988 @default.
- W2122520003 cites W4251627703 @default.
- W2122520003 cites W4251776002 @default.
- W2122520003 cites W4253187833 @default.
- W2122520003 doi "https://doi.org/10.1213/ane.0b013e3182025a8a" @default.
- W2122520003 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21156974" @default.
- W2122520003 hasPublicationYear "2011" @default.
- W2122520003 type Work @default.
- W2122520003 sameAs 2122520003 @default.
- W2122520003 citedByCount "47" @default.
- W2122520003 countsByYear W21225200032012 @default.
- W2122520003 countsByYear W21225200032013 @default.
- W2122520003 countsByYear W21225200032014 @default.
- W2122520003 countsByYear W21225200032015 @default.
- W2122520003 countsByYear W21225200032016 @default.
- W2122520003 countsByYear W21225200032017 @default.
- W2122520003 countsByYear W21225200032018 @default.
- W2122520003 countsByYear W21225200032019 @default.
- W2122520003 countsByYear W21225200032020 @default.
- W2122520003 countsByYear W21225200032021 @default.
- W2122520003 countsByYear W21225200032022 @default.
- W2122520003 countsByYear W21225200032023 @default.
- W2122520003 crossrefType "journal-article" @default.
- W2122520003 hasAuthorship W2122520003A5005595554 @default.
- W2122520003 hasAuthorship W2122520003A5006663041 @default.
- W2122520003 hasAuthorship W2122520003A5027565228 @default.
- W2122520003 hasAuthorship W2122520003A5034429046 @default.
- W2122520003 hasAuthorship W2122520003A5051774923 @default.
- W2122520003 hasAuthorship W2122520003A5052437588 @default.
- W2122520003 hasAuthorship W2122520003A5058897716 @default.
- W2122520003 hasAuthorship W2122520003A5070015565 @default.
- W2122520003 hasAuthorship W2122520003A5072213670 @default.
- W2122520003 hasAuthorship W2122520003A5073265415 @default.
- W2122520003 hasAuthorship W2122520003A5081758472 @default.
- W2122520003 hasAuthorship W2122520003A5083303292 @default.
- W2122520003 hasAuthorship W2122520003A5091887287 @default.
- W2122520003 hasBestOaLocation W21225200031 @default.
- W2122520003 hasConcept C126322002 @default.
- W2122520003 hasConcept C141071460 @default.
- W2122520003 hasConcept C142724271 @default.
- W2122520003 hasConcept C204787440 @default.
- W2122520003 hasConcept C27081682 @default.
- W2122520003 hasConcept C2776467144 @default.
- W2122520003 hasConcept C2778446825 @default.
- W2122520003 hasConcept C2778537899 @default.
- W2122520003 hasConcept C2779826273 @default.
- W2122520003 hasConcept C2779944601 @default.
- W2122520003 hasConcept C2780820201 @default.
- W2122520003 hasConcept C35785553 @default.
- W2122520003 hasConcept C42219234 @default.